Aqua Bio Technology — Major Shareholding Notification 2026

Mar 16, 2026

Aqua Bio Technology ASA: Disclosure of large shareholdings

Aqua Bio Technology ASA: Disclosure of large shareholdings

Reference is made to the stock exchange notice from Aqua Bio Technology ASA

("ABTEC" or the "Company") published on 13 March 2026 regarding the

Extraordinary General Meeting approving a NOK 50 million debt conversion with

the issuance of 10,000,000 new shares (the "New Shares") in the Company, at a

subscription price of NOK 5.00 per New Share (the "Debt Conversion").

The following shareholders of the Company have, on 14 March 2026, been

allocated New Shares in the Debt Conversion which implies that their holdings

have surpassed a notifiable threshold:

· Forza NO AS has been allocated 2,716,216 New Shares in the Debt Conversion.

Following this and upon completion of the Debt Conversion, Forza NO AS will

hold 3,096,473 shares in the Company, corresponding to 20.3% of the shares and

votes in the Company; and

· Terabyte Holding AS, a company controlled by ABTEC board member Terje Blytt,

has been allocated 2,310,811 New Shares in the Debt Conversion. Following this

and upon completion of the Debt Conversion, Terabyte Holding AS will hold

2,638,211 shares in the Company, corresponding to 17.3% of the shares and

votes in the Company; and

· Expo Holding AS, a company controlled by Martin Siem, has been allocated

1,891,892 New Shares in the Debt Conversion. Following this and upon

completion of the Debt Conversion, Martin Siem and associated companies will

hold 2,253,187 shares in the Company, corresponding to 14.8% of the shares and

votes in the Company; and

· Norlane AS, a company controlled by ABTEC chairman Roger Sedal, has been

allocated 1,662,162 New Shares in the Debt Conversion. Following this and upon

completion of the Debt Conversion, Norlane AS will hold 1,828,368 shares in

the Company, corresponding to 12.0% of the shares and votes in the Company;

and

· Dank I Halden AS has been allocated 1,418,919 New Shares in the Debt

Conversion. Following this and upon completion of the Debt Conversion, Dank I

Halden AS will hold 1,617,572 shares in the Company, corresponding to 10.6% of

the shares and votes in the Company.

The following shareholders have had their holdings diluted as a consequence of

the Debt Conversion, and thereby surpassed a notifiable threshold:

· Following completion of the Debt Conversion, RH Industri AS and Roger

Hofseth will hold 464,355 shares in the Company, corresponding to 3.0% of the

shares and votes in the Company; and

· Following completion of the Debt Conversion, Intelco AS and Øystein Tvenge

will hold 419,491 shares in the Company, corresponding to 2.8% of the shares

and votes in the Company; and

· Following completion of the Debt Conversion, PJUR Eiendom AS will hold

418,269 shares in the Company, corresponding to 2.7% of the shares and votes

in the Company.

The calculations in this notice are based on a total number of shares in the

Company of 15,227,935 following completion of the Debt Conversion, and

registration of the shares in the Norwegian Register of Business Enterprises.

This disclosure is made pursuant to section 4-2 of the Norwegian Securities

Trading Act.

Contacts

Kristian Flaten

CEO & CFO

Aqua Bio Technology ASA

Phone: +47 9509 2322

Email: kf@aquabiotech.no

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in

skincare and nonfood. The group has distribution towards B2C and B2B, and

offers freight, customs, and logistics services. The group also develops

sustainable biotechnology for use in skincare products. Aqua Bio Technology is

listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR. The information was submitted for publication, through the

agency of the contact persons set out above, at 2026-03-16 07:30 CET.